安全监测

不同质量等级款冬花中肝毒性吡咯里西啶生物碱含量研究*

  • 昝珂 ,
  • 吴芸 ,
  • 蔡喜生 ,
  • 王赵 ,
  • 王丹丹 ,
  • 金红宇 ,
  • 李海亮
展开
  • 1.中国食品药品检定研究院,北京 102629;
    2.泰州市药品检验院,泰州 225300;
    3.通化市食品药品检验所,通化 134001
第一作者 昝珂 Tel:(010)53852092;E-mail:6206310@qq.com
吴芸 Tel:(010)53851413;E-mail:502220641@qq.com
** 金红宇 Tel:(010)53852464;E-mail:jhyu@nifdc.org.cn
李海亮 Tel:(0523)86200636;E-mail:lihailiang@nifdc.org.cn

网络出版日期: 2025-10-13

基金资助

* 国家药监局中药材及饮片质量控制重点实验室开放基金项目(2023GSMPA-KL09); 中国食品药品检定研究院关键技术研究基金项目(GJJS-2022-7-1)

Studies on the content of hepatotoxic pyrrolizidine alkaloids in Farfarae Flos of different quality grades*

  • ZAN Ke ,
  • WU Yun ,
  • CAI Xi-sheng ,
  • WANG Zhao ,
  • WANG Dan-dan ,
  • JIN Hong-yu ,
  • LI Hai-liang
Expand
  • 1. National Institutes for Food and Drug Control, Beijing 102629, China;
    2. Taizhou Institute for Drug Control, Taizhou 225300, China;
    3. Tonghua Institutes for Food and Drug Control, Tonghua 134001, China

Online published: 2025-10-13

摘要

目的: 阐明不同质量等级的款冬花药材中吡咯里西啶生物碱含量差异。方法: 采用UPLC-MS/MS法建立同时测定不同质量等级款冬花中千里光宁碱、N-氧化千里光宁碱和克氏千里光碱等3个吡咯里西啶生物碱的含量。采用ACQUITY UPLC HSS T3色谱柱(150 mm×2.1 mm,1.8 μm),以0.5%甲酸水-甲醇(80 ∶ 20)为流动相,等度洗脱;电喷雾(ESI)离子源,正离子多反应模式监测,外标法测定。结果: 款冬花一等品、二等品和统货中千里光碱含量分别为0.06~0.16、0.20~0.49和0.39~1.02 μg · g-1,N-氧化千里光宁碱含量分别为0.89~1.66、3.61~5.12和4.47~7.87 μg · g-1,克氏千里光碱含量分别为46.53~85.00、122.95~227.43和153.83~282.59 μg · g-1;款冬花花蕾、花梗和根中千里光碱含量分别为0.07~0.18、0.60~1.16和0.22~1.65 μg · g-1,N-氧化千里光宁碱含量分别为0.64~1.59、0.91~9.78和1.58~5.89 μg · g-1,克氏千里光碱含量分别为51.35~82.22、176.329~246.80和321.00~343.30 μg · g-1。结论: 本研究揭示了款冬花中吡咯里西啶生物碱的含量与质量等级、药用部位的关系,为质量评价及标准提高提供了新思路。

本文引用格式

昝珂 , 吴芸 , 蔡喜生 , 王赵 , 王丹丹 , 金红宇 , 李海亮 . 不同质量等级款冬花中肝毒性吡咯里西啶生物碱含量研究*[J]. 药物分析杂志, 2025 , 45(4) : 702 -709 . DOI: 10.16155/j.0254-1793.2024-1032

Abstract

Objective: To elucidate the differences in the contents of pyrrolizidine alkaloids among different quality grades of Farfarae Flos. Methods: A UPLC-MS/MS method was established for simultaneous determination of three pyrrolizidine alkaloids, senecionine, senecionine N-oxide and senkirkine in Farfarae Flos of different quality grades.An ACQUITY UPLC HSS T3 column (150 mm×2.1 mm, 1.8 μm) was used, themobile phase was 0.5% formic acid water-methanol (80 ∶ 20) with isocratic elution. The MS system was operated by using electrospray ionization (ESI) in the positive ion mode, and the scan mode was in multiple reactions monitoring (MRM) mode. External standard method was used in the experiment. Results: The contents of senecionine in first-grade, second-grade, and ungraded Farfarae Flos were 0.06-0.16 μg · g-1, 0.20-0.49 μg · g-1 and 0.39-1.02 μg · g-1, respectively. The contents of senecionine N-oxide were 0.89-1.66 μg · g-1, 3.61-5.12 μg · g-1 and 4.47-7.87 μg · g-1, respectively. The contents of senkirkine were 46.53-85.00 μg · g-1, 122.95-227.43 μg · g-1 and 153.83-282.59 μg · g-1, respectively. In the flower buds, pedicels and roots of Farfarae Flos, the contents of senecionine were 0.07-0.18 μg · g-1,0.60-1.16 μg · g-1 and 0.22-1.65 μg · g-1, respectively. The contents of senecionine N-oxide were 0.64-1.59 μg · g-1,0.91-9.78 μg · g-1 and 1.58-5.89 μg · g-1, respectively. The contents of senkirkine were 51.35-82.22 μg · g-1, 176.29-246.80 μg · g-1and 321.00-343.30 μg · g-1, respectively. Conclusion: This study reveals the relationships between the content of pyrrolizidine alkaloids in Farfarae Flos and its quality grade and medicinal parts. These results provide new perspective for quality evaluation and standard improvement.

参考文献

[1] 中华人民共和国药典2020年版.一部[S].2020:346
ChP 2020.Vol Ⅰ[S].2020:346
[2] 刘佳,裴林,孙国强,等.款冬花的本草考证[J].中国现代应用药学,2018,35(2):204
LIU J,PEI L,SUN GQ,et al.Herbal authentication on Farfarae Flos[J].Chin J Mod Appl Pharm,2018,35(2):204
[3] 李安平,高坤,杨平荣,等.国家中药质量标准中含款冬花成方制剂的归纳与分析[J].中国现代中药,2022,24(3):542
LI AP,GAO K,YANG PR,et al.Summary and analysis of Chinese patent medicine containing Farfarae Flos in national quality standards of Chinese medicine[J].Mod Chin Med,2022,24(3):542
[4] 中国植物志编辑委员会.中国植物志.第77(1)卷[M].北京:科学出版社,1999:93
Editorial Committee of Chinese Journal of Plant of Chinese Academy of Sciences.Flora of China.Vol 77.Part 1[M].Beijing:Science Press,1999:93
[5] 熊芬,谷丽华,杨莉,等.含吡咯里西啶生物碱中成药潜在风险评估[J].中草药,2021,52(17):5389
XIONG F,GU LH,YANG L,et al.Risk evaluation of Chinese patent medicine containing pyrrolizidine alkaloids[J].Chin Tradit Herb Drugs,2021,52(17):5389
[6] 高江国,王长虹,李岩,等.吡咯里西啶生物碱的药理作用、毒性及药(毒)物代谢动力学研究进展[J].中国中药杂志,2009,34(5):506
GAO JG,WANG CH,LI Y,et al.Advance on pharmacologic actions,toxicity and pharmacokinetics of pyrrozidine alkaloids[J].China J Chin Mater Med,2009,34(5):506
[7] 王涛,宋海波.吡咯里西啶类生物碱肝毒性研究进展及风险分析[J].医药导报,2018,37(9):1033
WANG T,SONG HB.Research progress and risk analysis on hepatotoxicity of pyrrolizidine alkaloids[J].Her Med,2018,37(9):1033
[8] 郭严,张世荣,文良志,等.我国吡咯烷生物碱致肝窦阻塞综合征的临床特征分析[J].临床肝胆病杂志,2018,34(6):1277
GUO Y,ZHANG SR,WEN LZ,et al.Clinical features of sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids in China[J].J Clin Hepatol,2018,34(6):1277
[9] 孙潇翔,向娥,邱帅凯,等.吡咯里西啶生物碱毒性作用研究进展[J].中国药物警戒,2019,16(2):76
SUN XX,XIANG E,QIU SK,et al.Research progress on toxicity of pyrrolizidine alkaloids[J].Chin J Pharmacov,2019,16(2):76
[10] JI LL,ZHANG M,SHENG YC,et al.Pyrrolizidine alkaloid clivorine induces apoptosis in human normal liver L-02 cells and reduces the expression of p53 protein[J].Toxicol In Vitro,2005,19(1):41
[11] JI LL,ZHAO XG,CHEN L,et al.Pyrrolizidine alkaloid clivorine inhibits human normal liver L-02 cells growth and activates p38 mitogen-activated protein kinase in L-02 cells[J].Toxicon,2002,40(12):1685
[12] LIANG QN,LIU TY,JI LL,et al.Pyrrolizidine alkaloid clivorine-induced oxidative stress injury in human normal liver L-02 cells[J].Drug Discov Ther,2009,3(6):247
[13] ZHU L,XUE JY,HE YS,et al.Correlation Investigation between pyrrole-DNA and pyrrole-protein adducts in male ICR mice exposed to retrorsine,a hepatotoxic pyrrolizidine alkaloid[J].Toxins(Basel),2022,14(6):377
[14] 乔月,陈丽华,胡宏秀,等.基于UPLC-MS/MS同时测定款冬花咯里西啶生物碱及其氮氧化物的含量[J].中国实验方剂学杂志,2019,26(1):155
QIAO Y,CHEN LH,HU HX,et al.Simultaneous determination of pyrrolizidine alkaloids and their nitrogen oxides in Farfarae Flos by UPLC-MS/MS[J].Chin J Exp Tradit Med Form,2019,26(1):155
[15] 董爱军,张萌,王华翔,等.款冬花碱制前后毒性成分克氏千里光碱含量变化及初步风险评估[J].药物分析杂志,2023,43(9):1603
DONG AJ,ZHANG M,WANG HX,et al.Changes of the content of the toxic component senkirkine in crude and alkali processing Farfarae Flos and preliminary risk assenssment[J].Chin J Pharm Anal,2023,43(9):1603
[16] T/CACM 1021.93-2018中药材商品规格等级款冬花/CACM 1021.93-2018中药材商品规格等级款冬花[S].2018
T/CACM 1021.93-2018 Specification and Grade of Traditional Chinese Medicine Goods:Farfarae Flos/CACM 1021.93-2018 Specification and Grade of Traditional Chinese Medicine Goods:Farfarae Flos[S].2018
[17] 郑亚倩,曾慧婷,余炅,等.基于主成分分析-聚类分析的铁皮石斛鲜品品质评价研究[J].山东中医药大学学报,2024,48(4):467
ZHENG YQ,ZENG HT,YU J,et al.Quality evaluation of fresh Tiepishih(Dendrobii Caulis)based on principal component analysis and cluster analysis[J].J Shandong Univ Tradit Chin Med,2024,48(4):467
[18] The International Programme on Chemical Safety.Pyrrolizidine Alkaloids Health and Safety Guide[R].Health and Safety Criteria Guide 26.WHO:Geneva,1989
[19] MERZ KH,SCHRENK D.Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines[J].Toxicol Lett,2016,263:44
文章导航

/